Michael Ciesielski, PhD of Roswell Park Cancer Institute explains how the clinical data will help better characterize which patients respond to immunotherapy. Specifically, this data would tell clinicians which patients respond to the survivin vaccine. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Data Will Show Which Patients Respond to Immunotherapy
